Global Liquid Biopsy Market Size, Share, Opportunities, And Trends By Sample Tissue (Blood, Urine, Saliva, Others), By Biomarkers (Circulating Tumor Cells (CTCs), Circulating Tumor DNA (CTDNA), Cell-Free DNA (CFDNA), Extracellular Vesicles (EVs), Others), By Application (Screening, Disease Prognosis, Drug Response and Resistance), And By Geography - Forecasts From 2025 To 2030
Introduction1.1. Market Overview1.2. Scope of the Study1.3. Market Definition1.4. Market Segmentation 2. Research Methodology2.1. Research Data2.2. Assumptions 3. Executive Summary3.1. Research Highlights 4. Market Dynamics4.1. Market Drivers4.2. Market Restraints4.3. Porter's Five Forces Analysis4.3.1. Bargaining Power of End-Users4.3.2. Bargaining Power of Buyers4.3.3. Threat of New Entrants4.3.4. Threat of Substitutes4.3.5. Competitive Rivalry in the Industry4.4. Industry Value Chain Analysis 5. Global Liquid Biopsy Market Analysis, by Sample Tissue5.1. Introduction5.2. Blood5.3. Urine5.4. Saliva5.5. Others 6. Global Liquid Biopsy Market Analysis, by Biomarkers6.1. Introduction6.2. Circulating Tumor Cells (CTCs)6.3. Circulating Tumor DNA (ctDNA)6.4. Cell-Free DNA (cfDNA)6.5. Extracellular Vesicles (EVs)6.6. Others 7. Global Liquid Biopsy Market Analysis, by Application7.1. Introduction7.2. Screening7.3. Disease Prognosis7.4. Drug Response & Resistance 8. Global Liquid Biopsy Market Analysis, by Geography8.1. Introduction8.2. North America8.2.1. USA8.2.2. Canada8.2.3. Mexico8.3. South America8.3.1. Brazil8.3.2. Argentina8.3.3. Others8.4. Europe8.4.1. Germany8.4.2. France8.4.3. UK8.4.4. Italy8.4.5. Spain8.4.6. Others8.5. Middle East and Africa8.5.1. Saudi Arabia8.5.2. UAE8.5.3. South Africa8.5.4. Others8.6. Asia Pacific8.6.1. China8.6.2. India8.6.3. Japan8.6.4. South Korea8.6.5. Taiwan8.6.6. Thailand8.6.7. Indonesia8.6.8. Others 9. Competitive Environment and Analysis9.1. Major Players and Strategy Analysis9.2. Emerging Players and Market Lucrativeness9.3. Mergers, Acquisitions, Agreements, and Collaborations9.4. Vendor Competitiveness Matrix 10. Company Profiles 10.1. F. Hoffmann-La Roche AG10.2. Bio-Rad Laboratories, Inc.10.3. Genomic Health, Inc.10.4. Qiagen N.V.10.5. NeoGenomics Laboratories, Inc.10.6. Biocept, Inc.10.7. LungLife AI, Inc.10.8. Illumina, Inc.10.9. Cardiff Oncology10.10. Guardant Health, Inc.